AQST
Aquestive Therapeutics Inc
4.60$
+2.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -3.4% | +125.6% | -9.2% | -6.5% | -7.8% | +0.8% | -8.3% | +74.6% | -1.9% | -12.0% | -6.4% | |
| – | -3.5% | +176.8% | -8.3% | -7.2% | -8.6% | +1.1% | -8.4% | +85.6% | -1.6% | -12.8% | -9.0% | |
| – | -4.2% | +298.8% | -5.6% | -13.3% | -8.1% | -4.0% | -11.8% | +113.2% | -6.1% | -8.6% | -11.1% | |
| – | -4.2% | +298.8% | -5.6% | -13.3% | -8.1% | -4.0% | -11.8% | +113.2% | -6.1% | -8.6% | -11.1% | |
| – | -0.9% | -1.7% | -27.9% | +61.4% | -24.2% | +42.2% | +13.6% | -0.5% | +50.5% | -61.3% | +35.8% | |
| – | -4.4% | +14.3% | -9.9% | +0.8% | -13.9% | +19.1% | +12.9% | -3.0% | -21.8% | +30.8% | -8.7% | |
| – | -3.0% | -3.1% | – | – | – | – | – | – | – | – | – | |
| – | +0.9% | +1.2% | -7.7% | +1.5% | +4.0% | +1.0% | +1.9% | +0.8% | +15.8% | -9.7% | +7.7% | |
| – | -23.9% | -1.4% | -23.1% | +9.0% | +24.5% | -3.0% | +26.5% | +10.4% | +86.2% | -33.3% | -48.1% | |
| – | -91.7% | +6.1% | +9.6% | +5.8% | +5.7% | +5.8% | +560.8% | +126.6% | +36.9% | +31.8% | -94.6% | |
| – | -10.7% | +17.9% | -45.9% | +32.9% | +35.9% | +19.4% | -2.7% | -9.1% | +174.8% | -60.2% | -24.6% | |
| – | -20.4% | +4.5% | +4.3% | +4.2% | +4.0% | +3.8% | -5.6% | -6.0% | -8.1% | -8.8% | +101.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +6.0% | +7.4% | +23.5% | +0.2% | +0.1% | +4.7% | +4.0% | +11.3% | +10.3% | +0.5% | +1.9% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.